Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Anti-neutrophil cytoplasmic antibody-associated vasculitis accompanied by type II heparin-induced thrombocytopenia resulting in asymptomatic cerebral infarction: a case report

Fig. 2

The treatment course and changes in platelet count over time. The treatments involved steroid therapy with prednisolone (PSL), anticoagulant treatment during hemodialysis, intravenous cyclophosphamide (IVCY) therapy, and steroid pulse therapy with methylprednisolone (mPSL). The laboratory test parameters were changes in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) titers (red) and platelet counts (blue). The platelet counts improved after argatroban was started as anticoagulant treatment during hemodialysis

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us